GE Healthcare launches sterile genderless connector for disposable biopharma production
UK company GE Healthcare, a unit of General Electric, has launched a range of sterile genderless connectors as part of its ReadyToProcess portfolio of ready-to-use bioprocessing systems.
GE Healthcare has acquired exclusive rights to the Disposable Aseptic Connector (DAC), developed by BioQuate Inc., of Florida, and this is now a key component in GE Healthcare's fully disposable technology offering. The genderless DAC reduces complexity for customers by reducing parts inventory and requires no unique operator skills, power, calibration, or servicing.
GE Healthcare's new ReadyToProcess portfolio is designed to meet the biopharmaceutical industry's need for increased speed, simplicity and safety for all areas of bioprocessing, from cell culture and fermentation to final purification. Products currently available in the ReadyToProcess portfolio include single-use WAVE technologies and a set of newly developed, ready-to-use filtration and chromatography tools.
ReadyToProcess technologies allow considerable advantages over conventional methods used in bioprocessing, including: higher project throughput and shorter time-to-market due to the elimination of cleaning and cleaning validation steps, elimination of cross contamination problems and reduced training and certification of employees due to the convenience of a ready-to-use format.
"I am very pleased to join forces with GE Healthcare to bring genderless, disposable aseptic connectors to the market. GE Healthcare has a significant history in the market and will provide a vehicle to bring our DAC connection technology to a broad range of applications as well as providing a worldwide channel to the biotech market," said Ted Johnson, ceo of BioQuate.